Mesoblast Limited
MEOBF
$1.90
$0.2515.15%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.71% | 26.09% | 8.69% | -2.72% | -16.13% |
| Total Depreciation and Amortization | 34.14% | 60.81% | 100.46% | 67.54% | 37.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.82% | -27.23% | -15.15% | 3.30% | 30.34% |
| Change in Net Operating Assets | -682.87% | -2,995.39% | -1,371.26% | -2,206.08% | -15.62% |
| Cash from Operations | 12.26% | -11.87% | -40.20% | -20.44% | -3.09% |
| Capital Expenditure | -22.50% | -111.94% | -444.26% | -269.16% | -150.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.75% | -119.24% | -114.73% | -30.05% | 359.77% |
| Cash from Investing | -952.50% | -389.57% | -280.26% | -290.79% | 223.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,203.52% | -725.02% | -412.60% | -203.49% | 27.78% |
| Issuance of Common Stock | -93.82% | -6.49% | 530.91% | 264.51% | 154.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -112.00% | -103.14% | -92.45% | -24.64% | 20.21% |
| Cash from Financing | -110.40% | -10.93% | 3,329.17% | 567.13% | 266.03% |
| Foreign Exchange rate Adjustments | 41.87% | 519.09% | 212.11% | 262.35% | 2,080.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.48% | -43.61% | 332.63% | 497.92% | 1,279.60% |